Voto Christian, Panetta Thomas
College of Osteopathic Medicine, University of New England, Biddeford, USA.
Vascular Surgery, Mercy Medical Center, Rockville Centre, USA.
Cureus. 2021 Feb 19;13(2):e13446. doi: 10.7759/cureus.13446.
Introduction End-stage renal disease (ESRD) is a condition that has seen a large increase in prevalence in recent decades. Paralleling this increase in prevalence is the increasing number of patients requiring vascular access for hemodialysis. Arteriovenous fistulas (AVFs) and arteriovenous grafts (AVGs) are considered the procedures of choice for hemodialysis access. However, due to the suboptimal venous anatomy (<2 mm diameter, sclerotic vascular walls) and chronic medical conditions (diabetes mellitus) seen in many ESRD patients, successful AVF creation and maturation is not always possible using standard procedures. In this study, we performed primary balloon angioplasty (PBA) at the time of AVF creation with subsequent balloon angioplasty maturation (BAM) procedures in a group of patients with a large proportion of diabetes and suboptimal venous anatomy. The purpose of this study was to compare the assisted patency and survival rates in patients with suboptimal veins used to create AVFs to patients with standard vein AVFs and AVGs. Methods Over a nine-year period, PBA during AVF creation was performed 682 times. Of these, 551 AVFs were matured in optimally sized veins using standard BAM procedures, and 131 AVFs were matured in suboptimal veins utilizing a modified approach. In the subset of patients with suboptimal venous anatomy, we performed the initial BAM procedure via the radial artery utilizing a 4 French system. Additionally, routine clinical surveillance was scheduled throughout the study period for all patients. Suboptimal veins included small (<2 mm diameter), sclerotic, accessory, or recanalized veins. During the study period, 69 AVGs were created and matured using standard graft-gram procedures. A Kaplan-Meier analysis of survival and assisted patency rates comparing the three groups were calculated utilizing data from a retrospective database and medical records. A hazard ratio and a log-rank test were calculated to assess statistical significance. Results The mean time of follow-up for all three groups (n=703) was 43.2 months. Among patients requiring hemodialysis access in the study, the fistula creation rate was 90.8%. Patients with suitable venous anatomy who underwent AVF creation with PBA and standard BAM procedures experienced higher primary assisted patency rates relative to the suboptimal vein AVF and AVG groups (p<0.0001). No difference was seen between the suboptimal vein AVF and AVG groups. Patient survival and the percentage of diabetics were comparable amongst all three groups. Conclusion Using our approach, we were able to achieve a high AVF creation rate amongst a group of patients with a large proportion of suboptimal veins and diabetes. Despite not performing as well as standard vein AVFs in regards to primary assisted patency, the patients with suboptimal vein AVFs experienced similar patency and survival rates as compared to patients receiving AVGs. This new approach enhances the ability to create AVFs in patients who would otherwise not be amenable to fistulas and may contribute to reduced complication risk and improved overall survival.
引言 终末期肾病(ESRD)是一种近几十年来患病率大幅上升的疾病。与患病率上升并行的是,需要进行血管通路以进行血液透析的患者数量不断增加。动静脉内瘘(AVF)和动静脉移植物(AVG)被认为是血液透析通路的首选方法。然而,由于许多ESRD患者存在静脉解剖结构欠佳(直径<2毫米、血管壁硬化)和慢性疾病(糖尿病)等情况,使用标准程序并非总能成功创建和成熟AVF。在本研究中,我们对一组糖尿病患者比例高且静脉解剖结构欠佳的患者,在创建AVF时进行了初次球囊血管成形术(PBA),随后进行了球囊血管成形术成熟(BAM)程序。本研究的目的是比较用于创建AVF的静脉条件欠佳的患者与标准静脉AVF和AVG患者的辅助通畅率和生存率。
方法 在九年期间,AVF创建过程中进行PBA共682次。其中,551个AVF使用标准BAM程序在尺寸合适的静脉中成熟,131个AVF在静脉条件欠佳的情况下采用改良方法成熟。在静脉解剖结构欠佳的患者亚组中,我们通过桡动脉使用4法国系统进行了初始BAM程序。此外,在整个研究期间对所有患者进行了常规临床监测。静脉条件欠佳包括小静脉(直径<2毫米)、硬化静脉、副静脉或再通静脉。在研究期间,69个AVG使用标准移植物造影程序创建并成熟。利用回顾性数据库和病历数据,对三组患者的生存和辅助通畅率进行了Kaplan-Meier分析。计算了风险比和对数秩检验以评估统计学意义。
结果 所有三组(n = 703)的平均随访时间为43.2个月。在研究中需要血液透析通路的患者中,内瘘创建率为90.8%。与静脉条件欠佳的AVF和AVG组相比,采用PBA和标准BAM程序创建AVF且静脉解剖结构合适的患者的初次辅助通畅率更高(p<0.0001)。静脉条件欠佳的AVF和AVG组之间没有差异。所有三组患者的生存率和糖尿病患者百分比相当。
结论 使用我们的方法,我们能够在一组静脉条件欠佳和糖尿病患者比例高的患者中实现较高的AVF创建率。尽管在初次辅助通畅方面不如标准静脉AVF,但静脉条件欠佳的AVF患者与接受AVG的患者相比,通畅率和生存率相似。这种新方法提高了为原本不适合做内瘘的患者创建AVF的能力,并可能有助于降低并发症风险和提高总体生存率。